Ilyas SI - Search Results

1

Tomlinson JL, Valle JW, Ilyas SI. Tomlinson JL, et al. Among authors: ilyas si. J Hepatol. 2023 Sep;79(3):867-875. doi: 10.1016/j.jhep.2023.05.010. Epub 2023 May 16. J Hepatol. 2023. PMID: 37201670 Free PMC article. Review.

2

Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.

Fingas CD, Mertens JC, Razumilava N, Sydor S, Bronk SF, Christensen JD, Ilyas SI, Canbay A, Treckmann JW, Paul A, Sirica AE, Gores GJ. Fingas CD, et al. Among authors: ilyas si. Hepatology. 2013 Oct;58(4):1362-74. doi: 10.1002/hep.26484. Epub 2013 Aug 6. Hepatology. 2013. PMID: 23703673 Free PMC article.

3

Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Ilyas SI, Gores GJ. Ilyas SI, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.

4

Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

Ilyas SI, Borad MJ, Patel T, Gores GJ. Ilyas SI, et al. Semin Liver Dis. 2014 Nov;34(4):456-64. doi: 10.1055/s-0034-1394144. Epub 2014 Nov 4. Semin Liver Dis. 2014. PMID: 25369307 Free PMC article. Review.

5

IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Yamada D, Ilyas SI, Razumilava N, Bronk SF, Davila JI, Champion MD, Borad MJ, Bezerra JA, Chen X, Gores GJ. Yamada D, et al. Among authors: ilyas si. Hepatology. 2015 May;61(5):1627-42. doi: 10.1002/hep.27687. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25580681 Free PMC article.

6

Liver capsule: Cholangiocarcinoma (CCA).

Ilyas SI, Gores GJ. Ilyas SI, et al. Hepatology. 2016 Apr;63(4):1356. doi: 10.1002/hep.28401. Epub 2016 Feb 1. Hepatology. 2016. PMID: 26667406 Free PMC article. No abstract available.

7

A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.

Ilyas SI, Yamada D, Hirsova P, Bronk SF, Werneburg NW, Krishnan A, Salim W, Zhang L, Trushina E, Truty MJ, Gores GJ. Ilyas SI, et al. J Biol Chem. 2016 Apr 8;291(15):8031-47. doi: 10.1074/jbc.M115.698472. Epub 2016 Jan 29. J Biol Chem. 2016. PMID: 26826125 Free PMC article.

8

Emerging molecular therapeutic targets for cholangiocarcinoma.

Ilyas SI, Gores GJ. Ilyas SI, et al. J Hepatol. 2017 Sep;67(3):632-644. doi: 10.1016/j.jhep.2017.03.026. Epub 2017 Apr 5. J Hepatol. 2017. PMID: 28389139 Free PMC article. Review.

9

Targeting cholangiocarcinoma.

Mertens JC, Ilyas SI, Gores GJ. Mertens JC, et al. Among authors: ilyas si. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1454-1460. doi: 10.1016/j.bbadis.2017.08.027. Epub 2017 Aug 24. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28844952 Free PMC article. Review.

10

Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.

Kabashima A, Hirsova P, Bronk SF, Hernandez MC, Truty MJ, Ilyas SI, Kaufmann SH, Gores GJ. Kabashima A, et al. Among authors: ilyas si. J Hepatol. 2018 Jun;68(6):1228-1238. doi: 10.1016/j.jhep.2018.01.026. Epub 2018 Mar 9. J Hepatol. 2018. PMID: 29408314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters